GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.400 +0.120 (+3.66%)

Delayed Quote Updated: 11:23 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Government World Trade

GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?

February 17, 2026

GoodRx’s stock price has taken a beating over the past six months, shedding 56.5% of its value and falling to $2.23 per share. This was partly due to its softer quarterly results and may have investors...

Via StockStory

Topics Supply Chain

1 Healthcare Stock with Promising Prospects and 2 Facing Challenges

February 10, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

Via StockStory

Topics Stocks

Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. ↗

February 05, 2026

There's another fight brewing around GLP-1 drugs -- this time on the delivery side.

Via The Motley Fool

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

February 05, 2026

From GoodRx

Via Business Wire

1 Oversold Stock Set for a Comeback and 2 We Brush Off

February 04, 2026

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

February 02, 2026

From GoodRx

Via Business Wire

1 Stock Under $10 to Target This Week and 2 Facing Headwinds

February 01, 2026

Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack...

Via StockStory

1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question

January 29, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

January 28, 2026

From GoodRx Holdings, Inc.

Via Business Wire

Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

January 25, 2026

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx (NASDAQ:GDRX) and its peers.

Via StockStory

Surescripts and GoodRx Partner to Advance Patient Price Transparency

January 13, 2026

From Surescripts

Via Business Wire

GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

January 08, 2026

From GoodRx

Via Business Wire

Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗

January 05, 2026

The development comes as attention remains on Hims’ longer-term business expansion initiatives.

Via Stocktwits

GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

January 05, 2026

From GoodRx

Via Business Wire

1 Cash-Producing Stock to Keep an Eye On and 2 We Avoid

December 31, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

1 Value Stock to Target This Week and 2 Facing Headwinds

December 28, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

3 Healthcare Stocks We Approach with Caution

December 18, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

Via StockStory

Topics Stocks

GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 16, 2025

From GoodRx Holdings, Inc.

Via Business Wire

3 Stocks Under $10 That Fall Short

December 09, 2025

Via StockStory

Why GoodRx (GDRX) Stock Is Trading Lower Today

December 09, 2025

Shares of healthcare tech company GoodRx (NASDAQ:GDRX) fell 1.7% in the afternoon session after Barclays initiated coverage on the health-focused technology company with an "Underweight" rating and a...

Via StockStory

Topics Government

1 Profitable Stock Worth Your Attention and 2 We Turn Down

December 04, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies.

Via StockStory

Topics Economy Government

Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

3 Small-Cap Stocks That Fall Short

November 19, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Novo Nordisk Leans Into Affordability Amid Rising Competition ↗

November 17, 2025

Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger Wegovy pill rollout.

Via Benzinga

GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®

November 17, 2025

From GoodRx

Via Business Wire

5 Revealing Analyst Questions From GoodRx’s Q3 Earnings Call

November 11, 2025

GoodRx’s third quarter results were met with a moderate positive market response, as the company’s revenue modestly exceeded Wall Street expectations despite being flat year-over-year. Management...

Via StockStory

Topics Earnings

3 Value Stocks We Find Risky

November 09, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

3 Low-Volatility Stocks with Open Questions

November 05, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.